Bimekizumab: The First FDA-Approved Dual IL-17A/IL-17F Inhibitor for Plaque Psoriasis - A Comprehensive Literature Review
Bimekizumab:首个获FDA批准用于治疗斑块状银屑病的双重IL-17A/IL-17F抑制剂——综合文献综述
期刊:
影响因子:
doi:10.2147/PTT.S544166
Al Alshaikh, Sukainah Ahmed; Almarhoon, Zahra Mohammad; Momattin, Hisham; Aleid, Mahdi; Almousa, Zahra H; Alqaisum, Ali Kamal; Mobarki, Fatimah Ismail; Almakki, Sarah Aon; Alturfi, Hamzah; Almajed, Kouther Jamil